EUVIMEDEUVIMED entdecken
Crossref

Zn‐Based Multi‐Active Framework Nanoparticles TSA‐CAN‐Zn Inhibit Skin Glycation via Dual Blockade of HMGB1/RAGE and AGEs/RAGE Pathways

Cheng Yao, Heqi Wang, Jingxia Han, Kai Yang, Tingting Lin, Jing Jin, Caibin Zhu, Huijuan Liu iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202500664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Cheng Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cheermore Cosmetic Dermatology Laboratory, Shanghai, China. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, HMGB1 Protein, Skin, Receptor for Advanced Glycation End Products. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Technology Innovation Project of Nankai University & Zhiben Synthetic Biology Joint Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Receptor for advanced glycation end products (RAGE) plays an important role in skin glycation damage. High‐mobility group 1B protein (HMGB1) and advanced glycation end products (AGEs) are key RAGE ligands. Simultaneous inhibition of HMGB1/RAGE and AGEs/RAGE pathways maybe an effective strategy to alleviate glycation induced skin damage. In this work, Theasinensin A (TSA) is identified as the active molecule inhibiting HMGB1‐RAGE interaction through molecular docking. To simultaneously suppress HMGB1/RAGE and AGEs/RAGE pathways, Zn‐based multi‐active framework nanoparticles TSA‐CAN‐Zn are designed, which contain TSA and the active molecule L‐carnosine (CAN) that inhibits AGEs production. In vitro studies demonstrated that TSA‐CAN‐Zn have radical scavenging activity and AGEs formation inhibition activity. TSA‐CAN‐Zn can not only inhibit ROS accumulation, cell apoptosis, and inflammatory factors production induced by glycation in HaCaT cells but also enhanced the lysosomal degradation of AGEs. TSA‐CAN‐Zn also mitigated the damage caused by glycation in mouse skin glycation model. Single‐cell RNA sequencing results revealed the impact of TSA‐CAN‐Zn on different cell types of skin tissue, especially the basal cells of the epidermal layer and inflammation‐related macrophages. And pathway analysis revealed that TSA‐CAN‐Zn mainly influences the downstream pathways of RAGE. Collectively, TSA‐CAN‐Zn is a promising therapeutic candidate for ameliorating glycation‐induced skin damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycation End Products, AdvancedHMGB1 ProteinSkinReceptor for Advanced Glycation End ProductsNanoparticlesZincAnimalsHumansMiceCarnosineApoptosisGlycosylationSignal TransductionHaCaT CellsMolecular Docking Simulation

Stichwörter der Autor:innen

Zn‐based multi‐active framework nanoparticlesadvanced glycation end products (AGEs)high‐mobility group 1B protein (HMGB1)receptor for advanced glycation end products (RAGE)

Substanzen

Glycation End Products, AdvancedHMGB1 ProteinReceptor for Advanced Glycation End ProductsZincCarnosine

Autor:innen und Institutionen

  • Cheermore Cosmetic Dermatology Laboratory, Shanghai, China.
  • Shanghai Cheermore Aesthetic Clinic, Shanghai, China.
  • State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
  • Medical plastic and cosmetic center, Tianjin Branch of National Clinical Research Center for Ocular Disease, Tianjin Medical University Eye Hospital, Tianjin, China.

ORCID-Profile: Huijuan Liu

Förderung

  • Technology Innovation Project of Nankai University & Zhiben Synthetic Biology Joint Laboratory

Zitieren

APA

Yao, C., Wang, H., Han, J., Yang, K., Lin, T., Jin, J., Zhu, C., & Liu, H. (2025). Zn‐Based Multi‐Active Framework Nanoparticles TSA‐CAN‐Zn Inhibit Skin Glycation via Dual Blockade of HMGB1/RAGE and AGEs/RAGE Pathways. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500664

Vancouver

Yao C, Wang H, Han J, Yang K, Lin T, Jin J, et al. Zn‐Based Multi‐Active Framework Nanoparticles TSA‐CAN‐Zn Inhibit Skin Glycation via Dual Blockade of HMGB1/RAGE and AGEs/RAGE Pathways. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500664

BibTeX
@article{Yao2025,
  author = {Yao, Cheng and Wang, Heqi and Han, Jingxia and Yang, Kai and Lin, Tingting and Jin, Jing and Zhu, Caibin and Liu, Huijuan},
  title = {Zn‐Based Multi‐Active Framework Nanoparticles TSA‐CAN‐Zn Inhibit Skin Glycation via Dual Blockade of HMGB1/RAGE and AGEs/RAGE Pathways},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202500664}
}
Kostenlos starten →